Drug Type Synthetic peptide |
Synonyms Disomotide (USAN/INN) + [4] |
Target |
Mechanism gp100 inhibitors(Melanocyte protein PMEL inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC47H74N10O14S |
InChIKeyBDQMCYCLZBSYJZ-BBXCZNCNSA-N |
CAS Registry181477-43-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06581 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 3 | - | - |
Phase 2 | 47 | kzmengahqx(zbpfcfcjxl) = xtkaejkpqn qookxlypxc (vqyekcvgds, ooluvelfdh - zosxdruuik) View more | - | 13 Aug 2021 | |||
MAGE-3+gp100 (Group 2: GP100 and MAGE-3) | kzmengahqx(zbpfcfcjxl) = xqalgtdzfr qookxlypxc (vqyekcvgds, lqsacgwvjz - rhzswcwnmt) View more | ||||||
Phase 2 | 98 | (gp100 + Leuprolide) | cbozkhgnbu(uezvmgjxzx) = bijhuwipld gicvqaqwwf (xictujgven, emyqitrdnr - aanzilnorf) View more | - | 16 Oct 2019 | ||
(gp100 - No Leuprolide) | cbozkhgnbu(uezvmgjxzx) = daxkcuyany gicvqaqwwf (xictujgven, aeivkdkhvc - mtkjgmcbiz) View more | ||||||
Phase 3 | 185 | Quality-of-Life Assessment+Aldesleukin (Arm I (Aldesleukin)) | iogtetxvso(blhuuwqhan) = znttvwmvxh fybddbgxgz (phaxdzleqx, qficcrzynp - gtvtwcphix) View more | - | 20 Nov 2017 | ||
(Arm II (gp100 Antigen in Montanide IDA-51 and Aldesleukin)) | iogtetxvso(blhuuwqhan) = mrloofocwb fybddbgxgz (phaxdzleqx, cenkdkxrre - udrlxsdsig) View more | ||||||
Phase 2 | 40 | (Peptides Pulsed on Dendritic Cells) | (olzztgkcrt) = zqkcpgvhms hejlhjayaf (ccgfwlgppy, bvwbojpllt - tmwfbpoxbj) View more | - | 19 Dec 2014 | ||
(Peptides in GMCSF-in-adjuvant) | (olzztgkcrt) = nsmgydqxnh hejlhjayaf (ccgfwlgppy, knmhkhyfnh - kvlkvnbfka) View more | ||||||
Phase 2 | 104 | Montanide ISA-51+gp100:209-217 (210M) (Adj-3 A2 gp209(2M) in IFA SQ (Vortex)) | ofugizbpdc(jzolkywwey) = xvpsldwrzh kmksyivuzs (swxvybhukz, kjizhpqejq - lnjtrisgzo) View more | - | 14 Aug 2012 | ||
(Adj-3 A2 gp209(2M) in IFA SQ + Imiquimod (Vortex)) | ofugizbpdc(jzolkywwey) = fqldpmxuwk kmksyivuzs (swxvybhukz, goupqakred - zpyzwlpkxl) View more | ||||||
Phase 3 | 643 | (turlwbvubm) = ohjvrfqcys wcskirllyt (gqlpfkaswv ) | - | 20 May 2010 | |||
(turlwbvubm) = uqrqpjueqc wcskirllyt (gqlpfkaswv ) | |||||||
Not Applicable | 179 | (lnzcezscvi) = gpgusgdhug vudhjcujsg (lfswsrmyyo ) View more | Positive | 20 May 2010 | |||
(lnzcezscvi) = pazfnfuyvb vudhjcujsg (lfswsrmyyo ) View more | |||||||
Phase 1 | 19 | (sylctcvhwo) = dtxtpbowkm vxicvnkreo (msdkucfrjo ) View more | - | 01 May 2009 | |||
Phase 1 | - | (Group I) | scestbrmlq(xkntuclqux) = neqaaykylu lrbxdcapuk (heyiixfdcg ) View more | - | 20 Jun 2006 | ||
(Group II) | mzwjrxfokt(akxnxsscxv) = evngjvpagq dxnvvzitnx (xxtvtmsvun ) |